Company intelligence / Profile preview

RxFunction

Eden Prairie, Minnesota, United Statesrxfunction.com ↗

Ownership: Private
Employees: ~71
Development stage: Other

Overview

Walkasins has undergone clinical evaluation including the walk2Wellness long-term study to assess improvements in mobility and quality of life for people with peripheral neuropathy. The device provides tactile cues to help users correct balance and reduce fall risk. Clinical results have shown promise in improving gait and confidence in patients with sensory loss due to peripheral neuropathy. No pivotal trial or FDA approval summary found; device appears commercially available by prescription.

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapy
Industry: Assistive Medical Devices

Beyond the preview

Go deeper on RxFunction.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RxFunction.

Explore the full profile